Generics
We manufacture our products by following our customers’ and health authorities’ most stringent requirements. DMF documentation for all our products is prepared in accordance with the latest requirements of EDQM (CEP), ICH (EuDMF, CTD), and FDA (US DMF). Material and product testing is performed in line with the European and United States Pharmacopeias.
Monoclinic form (space group P21/m)
Therapeutic Area
Alimentary tract & metabolism
Status
Commercial
EU DMF readiness
US DMF readiness
Other documentation
Japanese DMF
CAS No.
54-21-7
Reference Product
N/A
Drug description
Sodium salicylate is the sodium salt of salicylic acid. It is used as an analgesic and antipyretic.
It is also a potential replacement for aspirin for people sensitive to it.
Mechanism of action:
Sodium salicylate is a non-selective COX inhibitor. It inhibits the two isoforms of cyclooxygenase, COX-1 and COX-2. sodium salicylate irreversibly acetylates cyclooxygenases thereby inhibiting prostaglandin synthesis and associated inflammation and pain.